A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/09/1997	CA2028626C Process for producing 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
12/09/1997	CA1339573C Pyrimido¬4,5-d\| pyrimidine derivatives for use as bronchodilators
12/09/1997	CA1339570C New 11-aryl steroid derivatives
12/07/1997	CA2195036A1 Bacteriocidal, antibacterial and bacteriostatic composition
12/06/1997	CA2206914A1 Antibiotic quinolones and derivatives
12/05/1997	CA2197058A1 Anti-inflammatory agent
12/04/1997	WO1997048409A1 Methods of cancer treatment using naaladase inhibitors
12/04/1997	WO1997045746A2 Prion protein binding proteins and uses thereof
12/04/1997	WO1997045736A1 Regulation of cytokine production in a hematopoietic cell
12/04/1997	WO1997045735A1 Method for monitoring t-cell reactivity
12/04/1997	WO1997045550A2 Mini-adenoviral vector
12/04/1997	WO1997045544A1 Antibodies to the ed-b domain of fibronectin, their construction and uses
12/04/1997	WO1997045538A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
12/04/1997	WO1997045528A2 Mammalian tolloid-like gene and protein
12/04/1997	WO1997045473A1 Absolute molecular weight polymers and methods for their use
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045444A1 Ebv ctl epitopes
12/04/1997	WO1997045442A1 Polycationic sterol derivatives as transfection agents
12/04/1997	WO1997045441A1 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS
12/04/1997	WO1997045440A1 Cytostatic sterols
12/04/1997	WO1997045437A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	WO1997045436A1 Carbohydrate derivatives and their solid-phase synthesis
12/04/1997	WO1997045430A1 Carbapenem antibiotic, composition and method of preparation
12/04/1997	WO1997045429A1 Beta-lactams
12/04/1997	WO1997045428A1 Novel pyridazine compounds
12/04/1997	WO1997045427A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
12/04/1997	WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
12/04/1997	WO1997045424A1 Aromatic amidine derivatives useful as selective thrombin inhibitors
12/04/1997	WO1997045423A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
12/04/1997	WO1997045421A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
12/04/1997	WO1997045419A1 Benzoxazinone dopamine d4 receptor antagonists
12/04/1997	WO1997045417A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/04/1997	WO1997045416A1 NEW DERIVATIVES OF 10,11-DIHYDRO-10-OXO-5H-DIBENZ/b,F/AZEPINE-5-CARBOXAMIDE
12/04/1997	WO1997045413A1 Substituted amidinobenzene derivatives and medicinal compositions thereof
12/04/1997	WO1997045412A1 A method of treating cancer
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045407A1 Novel anandamide amidase inhibitors as analgesic agents
12/04/1997	WO1997045405A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
12/04/1997	WO1997045403A1 Aryl substituted cyclic amines as selective dopamine d3 ligands
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045401A1 New guanidine derivatives, methods of preparing them and their use as drugs
12/04/1997	WO1997045400A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
12/04/1997	WO1997045397A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045142A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	WO1997045140A1 Concentrated antibody preparation
12/04/1997	WO1997045139A2 Il-12 as an adjuvant for bordetella pertussis vaccines
12/04/1997	WO1997045138A1 New improved formulation for treatment of thromboembolism
12/04/1997	WO1997045136A1 Lactoferrin variants and uses thereof
12/04/1997	WO1997045131A1 Compositions for use in embolizing blood vessels
12/04/1997	WO1997045130A1 Methods for sterilizing female mammals
12/04/1997	WO1997045129A1 Methods for sterilizing male mammals
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045125A1 USE OF ESTROGEN TO MODIFY THE AMOUNT OF SEROTONIN TRANSPORTER OR ITS mRNA
12/04/1997	WO1997045124A1 Pharmaceutical compositions
12/04/1997	WO1997045122A1 Suppositories
12/04/1997	WO1997045121A1 Preparation for percutaneous administration
12/04/1997	WO1997045120A1 Use of riminophenazines as antimicrobial and antimalarial agents
12/04/1997	WO1997045119A1 Use of substance p antagonists for treating social phobia
12/04/1997	WO1997045116A1 Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of hiv to uninfected cells and contraceptive compositions comprising the said derivatives
12/04/1997	WO1997045115A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	WO1997045114A1 The treatment of vascular disease with prostaglandins via a sustained-release dermal patch
12/04/1997	WO1997045113A1 Nsaids for regulating the reproductive cycle of domesticated animals
12/04/1997	WO1997045112A1 Remedy or preventive for hyperlipemia
12/04/1997	WO1997045111A1 Phenyl derivatives useful as blockers of chloride channels
12/04/1997	WO1997045110A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazine carboximidamide]
12/04/1997	WO1997045109A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazine carboximidamide]
12/04/1997	WO1997045108A1 Guanidino derivatives as inhibitors of the cytotoxic effect of peroxynitrite
12/04/1997	WO1997045107A1 Remedies for brain diseases
12/04/1997	WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	WO1997045101A1 USE OF α-ALKYLGLUCOSIDES AND α-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS
12/04/1997	WO1997045099A1 Use of labdanum furanoid diterpenoids for preparing cosmetic or pharmaceutical and skin cell culture media compositions
12/04/1997	WO1997045098A2 Esters of vitamin e as products for topical application
12/04/1997	WO1997045091A2 Sustained release oxycodone formulations with no fed/fast effect
12/04/1997	WO1997045069A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	WO1997045026A1 Improvements in or relating to compositions containing creatine
12/04/1997	WO1997041206A3 Von willebrand factor multimerase
12/04/1997	WO1997040134A3 Human dnase ii
12/04/1997	WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	WO1997038679A3 Fast disintegrating oral dosage form
12/04/1997	WO1997037689A3 Denaturants for sympathomimetic amine salts
12/04/1997	WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997	WO1997035568A3 Diclofenac/gamma-cyclodextrin inclusion compounds
12/04/1997	DE19622222A1 Use of sodium=proton exchange inhibitor
12/04/1997	DE19621681A1 Wäßrige Perlglanzkonzentrate Aqueous pearlescent concentrates
12/04/1997	CA2619901A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	CA2615696A1 Novel anandamide amidase inhibitors as analgesic agents
12/04/1997	CA2592932A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	CA2257433A1 Methods of cancer treatment using naaladase inhibitors
12/04/1997	CA2257148A1 Mini-adenoviral vector
12/04/1997	CA2256900A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	CA2256889A1 Pyridocarbazole derivatives having cgmp-pde inhibitory effect
12/04/1997	CA2256693A1 Method for monitoring t-cell reactivity
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997	CA2256453A1 Lactoferrin variants and uses thereof
12/04/1997	CA2256404A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
12/04/1997	CA2256403A1 Esters of vitamin e as products for topical application

1 ... 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 ... 7860